Search alternatives:
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
-
761
-
762
Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl...
Published 2025“…The hyperglycaemic state was maintained till the end of the study as represented by the elevated blood glucose levels measured on the last day of the treatment regime. (c) Vitamin D3 and the positive control Cisplatin differently modulated FBG in hyperglycaemic mice: Intraperitoneal administration of vitamin D3 very minimally decreased FBG compared to vehicle control at the end of the study. …”
-
763
-
764
-
765
Pre and post COVID-19 Genexpert tests for TB detection trends over 8 months.
Published 2024Subjects: -
766
A T-test mean comparison of pre and post COVID-19 differences for selected variables.
Published 2024Subjects: -
767
-
768
-
769
-
770
-
771
Number and types of total TB patient on follow-up during pre and post COVID-19.
Published 2024Subjects: -
772
Pre and post COVID-19 positive test results of TB detection trends over 8 months.
Published 2024Subjects: -
773
-
774
-
775
-
776
-
777
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: “…guiding personalized treatment…”
-
778
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: “…guiding personalized treatment…”
-
779
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: “…guiding personalized treatment…”
-
780
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025Subjects: “…guiding personalized treatment…”